Objective Although both atrial fibrillation (AF) and gastroesophageal reflux disease (GERD) are common diseases, the relationship between these two conditions remains controversial, depending on the study design and type of AF. Therefore, we focused on the relationship between nonvalvular AF and GERD. Methods A total of 479 consecutive subjects (255 men and 224 women, mean age: 60.4 ± 12.8 years), including outpatients at several hospitals (n=201) and participants of an annual health screening program (n= 278), were enrolled. Subjects with valvular AF, malignancy or dementia were excluded. The frequency scale for symptoms of GERD (F-scale) was applied after obtaining each patient's informed consent for screening symptomatic GERD with a total cutoff score of 8 points. The score on the questionnaire was correlated with the baseline characteristics extracted from the patients' medical records. Results The total F-scale scores were significantly higher in the older patients (! 60 years) than in the younger patients (<60 years) (p=0.017) and increased in the following order: permanent AF > paroxysmal AF > sinus rhythm (p=0.003). The incidence of GERD increased in the same order among the patients with the various heart rhythm classifications (p<0.001). Coronary heart disease, hypertension, diabetes and dyslipidemia were not correlated with the F-scale scores or incidence of GERD. The stepwise discriminant analyses demonstrated that nonvalvular AF alone was significantly associated with symptomatic GERD (Wilks' lambda=0.983, p=0.004). Conclusion This multicenter study demonstrated that nonvalvular AF is significantly correlated with symptomatic GERD. This small sample survey warrants a future study of a large-scale cohort.
Introduction
Atrial fibrillation (AF) is a common arrhythmia encountered in clinical practice. AF is known to be agedependent (1) , and new risk factors for AF have emerged, such as sleep apnea (2) and metabolic syndrome (3). Gastroesophageal reflux disease (GERD) is drawing increasing attention due to the modern lifestyle, prevalence of obesity (4), sleep apnea (5) and metabolic syndrome (6) , progression of aging and decline of Helicobacter pylori infection in developed countries (7) . Lower esophageal sphincter relaxation is frequently observed in obese populations (4) and those with a full stomach (8) or sleep apnea (5), whereas hiatal hernias are prevalent in the elderly (9) .
Although AF and GERD share the same predisposing factors, including metabolic syndrome (3, 6) , sleep apnea (2, 5) and senescence (1, 9) , their association remains controversial. We conducted a preliminary questionnaire study and reported that the coexistence of AF and GERD is not unusual in Japan (10) . However, this multicenter survey was hospital-based, and hence significant bias may have been included. The extent of the link between AF and GERD may vary depending on the type of AF. Therefore, we focused on nonvalvular AF, an increasing subset of AF. The aim of this study was to investigate the relationship between nonvalvular AF and GERD in a wide range of subjects, including general hospital outpatients and participants of a health screening program.
Materials and Methods

Study subjects
This study was approved by the Institutional Review Board of Ethics in Research and performed from April 2008 to December 2011 according to the Declaration of Helsinki (2009). Four hundred and seventy-nine consecutive subjects (255 men and 224 women, mean age: 60.4±12.8 years) were enrolled in this study. The subjects included 201 outpatients who were followed monthly at Kyushu University Hospital or affiliated hospitals or clinics and 278 participants of a community-based annual health screening program. The outpatient clinics primarily cover cardiovascular medicine and additionally general or geriatric medicine. Patients with malignancy or dementia were excluded. The frequency scale for symptoms of GERD (F-scale) was applied in the waiting room of the outpatient clinic or health screening venue after obtaining the patient's informed consent.
F-scale for GERD
The F-scale is a widely used formulated questionnaire designed specifically to screen GERD (11) . It covers the 12 most common symptoms of GERD. The symptoms were scored based on frequency as follows: never=0, occasionally=1, sometimes=2, often=3 or always=4 (Table 1) . Therefore, the total score of the F-scale reflects the presence of GERD-related symptoms semiquantitatively. This questionnaire is composed of two parts, namely seven items relating to reflux-like symptoms and five items relating to dysmotility-like dyspeptic symptoms. F-scale questions numbered 2, 3, 5, 8 and 11 are related to dyspeptic symptoms, while the remaining questions concern reflux symptoms. Therefore, the total F-scale scores and the scores relating to reflux symptoms and dyspeptic symptoms were analyzed separately. The cutoff value for the total score to diagnose symptomatic GERD was set at 8 points, which is reported to yield a sensitivity of 62%, a specificity of 59% and a diagnostic accuracy of 60% as a reference for endoscopy (11) . Furthermore, the scale stability over time and internal consistency were preliminarily analyzed using a portion of the enrolled subjects (n=28).
Protocol
The baseline characteristics and treatments, if any, were explored based on the patients' medical records. Blood pressure was measured twice in the sitting position using a sphygmomanometer. Standard ECG and chest X-ray analyses were conducted as routine examinations. A blood examination was performed in all outpatients and health screening participants after overnight fasting. Coronary heart disease included old myocardial infarction and stable angina pectoris. Some subjects with this disease underwent coronary artery bypass grafting or percutaneous coronary intervention. Patients with acute coronary syndrome were excluded. Hypertension was defined as a blood pressure of ! 140/90 mmHg and/or ongoing antihypertensive treatment. Diabetes was defined as a fasting blood glucose level of ! 126 mg/dL, a casual blood glucose level of ! 200 mg/dL, an HbA1c level of ! 6.5% and/or current antidiabetic medication use (12) . Dyslipidemia was defined as an LDL cholesterol level of ! 140 mg/dL, an HDL cholesterol level of <40 mg/ dL or the prescription of lipid-lowering agents (12, 13) . AF patients with rheumatic mitral valve disease, an episode of mitral valve replacement or valvuloplasty were excluded. Therefore, AF was nonvalvular in the enrolled subjects. Paroxysmal or permanent AF was defined according to the 2012 HRS/EHRA/ECAS consensus reports (14) . Some patients with nonvalvular AF in the outpatient group (n=55) were subjects included in our recent article (10) . Holter monitoring and transthoracic echocardiography were conducted at the discretion of the treating physicians, as appro- priate. The F-scale scores were correlated with the demographic variables extracted from the medical records. The assignment and analysis of the F-scale scores were performed by different physicians. Therefore, the physicians who analyzed the F-scale scores were unaware of the patients' characteristics.
Statistical analysis
Continuous data are expressed as the mean ± SD and discrete variables are indicated as numbers and percentages. In the questionnaire analysis, the F-scale scores were evaluated separately from highly (! 8 point) rated scores, that is, the incidence of GERD. The data distribution was examined using the Kolmogorov-Smirnov test for normality. Intergroup differences of normally distributed data were compared using a one-way analysis of variance (ANOVA) and Dunnett's multiple comparisons. For nonparametric data, the MannWhitney U test or Kruskal-Wallis test were used. Discrete variables were analyzed as a cross table using Fisher's exact test or Pearson's χ 2 test with Yate's continuity correction, if necessary. This questionnaire survey did not anticipate dropout cases, and hence the sample size was chosen to provide 90% power with an α error of 0.05 based on our preliminary questionnaire survey and should have included 388 cases in total (10) . The baseline patient characteristics were incorporated into a univariate analysis, and variables showing significance with respect to the total F-scale score or clinically meaningful variables were incorporated into a multivariate analysis. These analyses were performed using a stepwise discriminant analysis to detect independent contributors to GERD. The practical computation was performed using the Predictive Analytics Software (PASW) 18.0 version for Windows package (SPSS Inc., IBM, Chicago, IL, USA). A difference with a two-sided p value of <0.050 was considered to indicate statistical significance.
Results
The baseline characteristics of the enrolled subjects are shown in Table 2 . There were no differences in gender distribution between the two groups (p=0.404). The outpatients were significantly (p<0.001) older than the health screening participants. All listed common diseases were significantly (p<0.001) more prevalent in the outpatient group than in the participant group. In terms of medications, proton pump inhibitors (PPIs: rabeprazole and lansoprazole) were prescribed to 41.8% of the outpatients, while calcium channel blockers (CCBs) were prescribed to 44.3% of the outpatients for the treatment of hypertension or angina pectoris and rate control of AF. CCBs, PPIs, statins, antidiabetic agents, antiarrhythmic agents and anticoagulants were prescribed more frequently in the outpatient group than in the participant group (p<0.001).
Although the responses to the F-scale were provided voluntarily, all subjects completed the disease-specific questionnaire. The validity of the F-scale was assessed by sampling 28 patients (18 outpatients and 10 participants). The internal consistency was satisfactory; that is, Cronbach's α values for the reflux score, dyspeptic score and total score were 0.735, 0.623 and 0.806, respectively. The scale stability over time was satisfactory in that Spearman's sign-rank correlation coefficient of repeated questionnaires with an interval of three months was 0.892 for the reflux score, 0.945 for the dyspeptic score and 0.931 for the total score. Table 3 indicates the differences in the F-scale scores and the incidence of GERD between the two groups. The Kolmogorov-Smirnov test confirmed that the score distribution was not normal (p<0.001). The three categories of Fscale scores (reflux, dyspeptic and total scores) of the outpatient group were significantly higher than the respective scores of the participant group. However, the incidence of GERD evaluated according to a high (! 8 point) score in the Table 4 shows the relationship between the incidence of GERD and the baseline characteristics in all of the enrolled subjects. There were no gender-specific differences with respect to the reflux score (p=0.249), dyspeptic score (p= 0.789), total score (p=0.521) or high (! 8 point) score rate (p=0.557). On the other hand, there was a highly significant trend of age dependence in the average scores, that is, the reflux score (p<0.001), dyspeptic score (p=0.003) and total score (p<0.001) among the subjects ! 60 years of age were higher than the corresponding scores among the subjects <60 years of age, with remarkable significance. However, there were no significant differences in the high (! 8 point) score rate, namely the incidence of GERD, between the two groups (p=0.807).
The three types of scores and high score rates were compared between the subjects with and without various common diseases. Hypertension exhibited a significant influence on the three types of scores; namely, the reflux, dyspeptic and total scores in the hypertensive patients were significantly higher than those observed in the controls. The same was true for the patients with dyslipidemia. Among the patients with coronary heart disease, the reflux score and total score, but not the dyspeptic score, exhibited significant differences. No significant differences in these scores were observed in the diabetic patients. Concerning hypertension, dyslipidemia, diabetes and coronary heart disease, none of these conditions demonstrated a significant impact on the incidence of symptomatic GERD (Table 4) .
With respect to the heart rhythm classification, 61 subjects exhibited permanent AF, as did 25 subjects with paroxysmal AF and 393 subjects with a sinus rhythm. The average total score was 3.15±3.58 in the patients with permanent AF, 2.72±3.01 in the patients with paroxysmal AF and 1.70±3.25 in the patient with a sinus rhythm. The KruskalWallis test yielded significant (p<0.001) differences in the average reflux score (p=0.001), dyspeptic score (p<0.001) and total score (p<0.001) between the three groups. Moreover, Pearson's χ 2 test yielded a highly significant (p<0.001) difference in the distribution of symptomatic GERD among the three groups (Table 4) . Considering the reported age dependence of AF (1), the age distribution among the three groups with different heart rhythms was investigated (data not shown). The ANOVA yielded a significant (p<0.001) age difference between the three groups with different heart rhythms. Dunnett's multiple comparison revealed highly significant (p<0.001) differences in the mean age between the sinus rhythm group (58.2±12.4 years) and the paroxysmal AF group (67.4±8.6 years) and between the sinus rhythm group and the permanent AF group (71.8±10.0 years). However, there were no differences in age between the paroxysmal and permanent AF groups (p=0.215). Table 5 shows the results of the stepwise discriminant analyses. The univariate analysis concerning the incidence of GERD showed no age dependence (p=0.656) and demonstrated that only AF patients exhibited a significant (p= 0.004) increase in the incidence of GERD. A multivariate analysis was performed by incorporating the baseline patient characteristics showing significance in the score analysis ( Table 4 ). As shown in Table 5 , AF alone remained an independent risk factor for symptomatic GERD (Wilks' lambda= 0.983, p=0.004).
Discussion
Main findings
In this multicenter GERD-specific questionnaire study, diseases relating to lifestyle, such as hypertension and dyslipidemia, but not diabetes, increased the F-scale scores. However, these common diseases were not associated with an increase in the incidence of symptomatic GERD. On the other hand, nonvalvular AF exhibited a close relationship with the F-scale scores and the incidence of GERD; namely, GERD was significantly more prevalent (p<0.001) among the subject groups in the following order: permanent AF > paroxysmal AF > sinus rhythm (Table 4 ). The multivariate analysis suggested that nonvalvular AF was most closely associated with GERD among the lifestyle-related common diseases (Table 5) .
Association between AF and GERD
Historically, an association between esophageal hernias and sustained atrial arrhythmia has been reported in the literature in case reports and case series studies (15, 16) . In this century, Weigl et al. (17) found 18 patients with lone AF among 89 patients with GERD and reported the therapeutic effects of PPIs on AF symptoms in 14 of the 18 patients (78%). Likewise, Gerson et al. (18) reported that acid reflux coincides with paroxysms of AF and that PPI therapy suppresses both acid reflux and AF paroxysms on simultaneous Holter and esophageal pH monitoring. Since patients with overlap of AF and GERD demonstrate a lower quality of life and require more health care resources (19) , these findings highlight a serious health-related problem.
Thus far, large sample studies assessing this association have shown conflicting results. For example, Bunch et al. (20) investigated the potential association between AF and GERD in U.S. residents using a self-reported questionnaire and found no relationships between the two diseases. In contrast, Kunz et al. (21) and Huang et al. (22) reported a significant correlation using a database of health care system encounters. One reason for this discrepancy is that the diagnosis of AF is based on ICD-9 codes, and subclinical, asymptomatic AF may have been undetected in these large sample studies. As suspected by Velagapudi et al. (23), GERD-related AF seems to be a distinct subset of the diverse spectrum of AF. Therefore, we focused on nonvalvular AF in this study of two populations of enrolled subjects to avoid selection bias. This type of AF is linked to several components of metabolic syndrome (3) that are also risk factors for GERD (4, 6) . This study demonstrated that there is a close link between GERD and nonvalvular AF in a wide range of subjects with different baseline profiles. In line with this finding, we are considering conducting a pilot study sampling a specific subgroup of patients with postprandial paroxysm of AF in order to investigate the use of PPIs as an adjunctive treatment for AF.
Mechanisms underlying the development of GERDrelated AF
Thus far, autonomic and anatomical mechanisms have been postulated regarding the role of AF as a risk factor for symptomatic GERD. Prandial paroxysm of AF is mediated by an augmented efferent vagal nerve activity, which induces gastric juice secretion and esophageal sphincter relaxation, leading to acid reflux (24) . The left atrium (LA) is in contact with the lower esophagus. Therefore, enlarged fibrillating LA may compress or irritate the neighboring lower esophagus, which is reported to cause various esophageal symptoms (25) .
The association between GERD and AF was first reported by Tougas et al. (26) who examined the effects of mechanical and/or electrical esophageal stimulation on the power spectral analyses of heart rate variability obtained via ambulatory monitoring. They reported that esophageal stimulation decreases the heart rate, increases the high-frequency spectral component and reduces the low-frequency power, thus suggesting that esophageal stimulation potentiates the efferent vagal nerve activity. These autonomic trends are the same as those observed prior to the initiation of paroxysmal AF (27) and the early recurrence of persistent AF following electrical cardioversion (28, 29) . Therefore, GERD is linked to AF from the autonomic viewpoint, although it is unknown whether this link is causative or correlative.
Recently, local inflammation has been shown to involve the pathophysiology of both AF and GERD; that is, LA inflammation is observed in AF patients (30) . The highsensitivity CRP level is correlated with the incidence (31, 32) , defibrillation efficacy (33), recurrence (34) and prognosis of AF (35) . Recurrent acid reflux also induces low-grade persistent inflammation and the secretion of cytokines, such as IL1β and IL6 (36) . These inflammatory cytokines are also involved in the initiation and maintenance of nonvalvular AF (30, 37, 38) .
Limitations
This study is associated with a few limitations. First, the inherently cross-sectional nature of this questionnaire study permits the inclusion of patients with undetected, asymptomatic paroxysm of AF, and the study design could not be used to follow patients over time to confirm the causal relationship between AF and GERD. The second limitation is the lack of endoscopic findings, which could not distinguish GERD from reflux esophagitis. As to the third limitation, the treatment of the subjects was at the discretion of the attending physicians. CCBs allowing for lower esophageal sphincter relaxation were prescribed in 22.1% of the subjects, and warfarin was prescribed in the AF patients. These two agents are prone to aggravating symptomatic GERD, based on the findings of our recent study (39) . PPIs were prescribed in 84 patients at the outpatient clinics (41.8%). However, the total F-scale scores of the PPI-treated outpatients were paradoxically higher than those of the untreated patients (3.41±0.20 vs. 2.34±0.33, p=0.020), highlighting the drawback of a cross-sectional design.
Conclusion
The association between AF and GERD is reported to be mediated by inflammatory and autonomic mechanisms in the anatomical vicinity. The present multicenter survey using a stable and internally consistent questionnaire demonstrated that this association is strengthened by focusing on nonvalvular AF; that is, this type of AF is significantly correlated with symptomatic GERD. The potential therapeutic role of PPIs in treating symptomatic nonvalvular AF merits future study of another cohort.
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